
Board Meeting22 Oct 2026, 02:49 pm
Lincoln Pharmaceuticals Board Meeting on Oct 29 to Approve Results
AI Summary
Lincoln Pharmaceuticals Ltd has announced that its Board of Directors will convene on October 29, 2026. The primary agenda item is to consider and approve the un-audited financial results, both standalone and consolidated, for the quarter and half-year ended September 30, 2026. The trading window for securities has been closed from October 1, 2026, and will reopen 48 hours after the results are made public.
Key Highlights
- Board meeting scheduled for October 29, 2026.
- To approve un-audited financial results for Q2 FY27.
- Results will be standalone and consolidated.
- Trading window closed from October 1, 2026.
Price Impact
More from LINCOLN